Sonic Healthcare Limited
SHL
Helyezés a részvények között
#2829
Sonic Healthcare Limited delivers medical diagnostic services to a diverse... Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
Részvényárfolyam
$13.26
Piaci kapitalizáció
$6.55B
Változás (1 nap)
-0.21%
Változás (1 év)
-4.48%
Ország
AU
Kereskedés Sonic Healthcare Limited (SHL)
Kategória
Healthcare
Sonic Healthcare Limited (SHL) nyeresége
Nyereség ekkor: Jun 2026 TTM: $581.53M
Sonic Healthcare Limited legfrissebb pénzügyi jelentései szerint a vállalat jelenlegi nyeresége $581.53M. 2024 évben a vállalat $487.85M nyereséget ért el, csökkenés a 2023 év nyereségéhez, amely $620.44M volt. Az ezen az oldalon megjelenített nyereség a kamatok és adók előtti eredmény, azaz EBIT.
Sonic Healthcare Limited nyereségtörténete 2000 és 2026 között
Nyereség az év végén
| Év | Nyereség | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $581.53M | 17.65% |
| 2025 | $494.30M | 1.32% |
| 2024 | $487.85M | -21.37% |
| 2023 | $620.44M | -56.70% |
| 2022 | $1.43B | 4.50% |
| 2021 | $1.37B | 184.25% |
| 2020 | $482.35M | -4.91% |
| 2019 | $507.24M | 11.00% |
| 2018 | $456.95M | 3.07% |
| 2017 | $443.36M | -0.42% |
| 2016 | $445.22M | 24.81% |
| 2015 | $356.72M | -26.56% |
| 2014 | $485.74M | 19.92% |
| 2013 | $405.04M | -5.17% |
| 2012 | $427.14M | 2.04% |
| 2011 | $418.61M | 27.85% |
| 2010 | $327.42M | 62.12% |
| 2009 | $201.96M | -36.56% |
| 2008 | $318.35M | 29.08% |
| 2007 | $246.63M | 25.90% |
| 2006 | $195.89M | 69.95% |
| 2005 | $115.26M | 60.97% |
| 2004 | $71.61M | 36.20% |
| 2003 | $52.57M | 41.85% |
| 2002 | $37.06M | 31.08% |
| 2001 | $28.27M | 16.52% |
| 2000 | $24.26M | 0.00% |
Hasonló cégek vagy versenytársak nyeresége
| Vállalat | Nyereség | Nyereségkülönbség | Ország |
|---|---|---|---|
| $7.61B | 1,208.44% |
US
|
|
| $4.76B | 718.87% |
US
|
|
| $-252.70M | -143.45% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 185.11% |
US
|
